ANVS
Annovis Bio Inc.
Company Overview
| Mkt Cap | $45.21M | Price | $2.01 |
| Volume | 234.26K | Change | -4.29% |
| P/E Ratio | -1.8 | Open | $2.08 |
| Revenue | -- | Prev Close | $2.10 |
| Net Income | $-24.6M | 52W Range | $1.11 - $9.23 |
| Div Yield | N/A | Target | $11.67 |
| Overall | 38 | Value | 60 |
| Quality | 23 | Technical | 33 |
No chart data available
Stock Overview
Updated DailyAnnovis Bio Inc. (ANVS) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $2.01 with a market capitalization of $45.21 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows ANVS with a volume of 234K shares. The stock opened down 0.95% from yesterday's close of $2.10. Current analyst estimates project earnings of $-1.41 per share for this year, with next year targeting $-1.51.
ANVS demonstrates concerning technical signals based on technical analysis. The company trades on the NYE exchange and operates alongside industry peers including SEAC, ANET, NCR, AVID.
Key investment considerations for ANVS include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 480.6%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:27 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ANVS | $2.01 | -4.3% | 234.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |